c.draganov
TL1 Member · Kaunas, LT
Newer member working through the reference pages before asking anything.
Joined 19 January 2025 · last posted 3d
27Posts here
0Topics
0Solutions
124Likes received
89Likes given
10Badges
73Days visited
326Posts read
Most-liked posts
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #116 · Compounds › Semaglutide · 11 Feb 2026 · 30 likes post #115 is right about the mechanism and I think understates the practical bit. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #93 · Start Here › Welcome · 21 Oct 2025 · 25 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #8 · Compounds › Semaglutide · 10 Sep 2025 · 25 likes post #7 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #31 · Compounds › Tirzepatide · 2 Mar 2026 · 23 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #110 · Compounds › Repair & healing peptides · 21 Nov 2024 · 19 likes This follows post #107 rather than contradicting it. BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #37 · Compounds › Repair & healing peptides · 11 Jun 2025 · 14 likes Oral versus injected administration claims for BPC-157: the preclinical work studied injection. Oral claims are common in supplier marketing and poorly supported by…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Basic User | bronze | 20 Jan 2025 |
| Read the Guidelines | bronze | 20 Jan 2025 |
| First Reply | bronze | 21 Jan 2025 |
| Welcome | bronze | 26 Jan 2025 |
| Asked Well | bronze | 6 Feb 2025 |
| First Link | bronze | 16 Feb 2025 |
| First Quote | bronze | 25 Feb 2025 |
| Nice Post | bronze | 28 Feb 2025 |
| Good Post | silver | 31 Jul 2025 |
| Anniversary | silver | 19 Jan 2026 |